Suppr超能文献

心房重构与心房颤动:机制相互作用及临床意义

Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.

作者信息

Al Ghamdi Bandar, Hassan Walid

机构信息

King Faisal Specialist Hospital and research centre, Riyadh, Saudi Arabia.

出版信息

J Atr Fibrillation. 2009 Jun 1;2(1):125. doi: 10.4022/jafib.125. eCollection 2009 Jun-Jul.

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. The prevalence of AF increases dramatically with age and is seen in as high as 9% of individuals by the age of 80 years. In high-risk patients, the thromboembolic stroke risk can be as high as 9% per year and is associated with a 2-fold increase in mortality. Although the pathophysiological mechanism underlying the genesis of AF has been the focus of many studies, it remains only partially understood. Conventional theories focused on the presence of multiple re-entrant circuits originating in the atria that are asynchronous and conducted at various velocities through tissues with various refractory periods. Recently, rapidly firing atrial activity in the muscular sleeves at the pulmonary veins ostia or inside the pulmonary veins have been described as potential mechanism,. AF results from a complex interaction between various initiating triggers and development of abnormal atrial tissue substrate. The development of AF leads to structural and electrical changes in the atria, a process known as remodeling. To have effective surgical or catheter ablation of AF good understanding of the possible mechanism(s) is crucial.Once initiated, AF alters atrial electrical and structural properties that promote its maintenance and recurrence. The role of atrial remodeling (AR) in the development and maintenance of AF has been the subject of many animal and human studies over the past 10-15 years. This review will discuss the mechanisms of AR, the structural, electrophysiologic, and neurohormonal changes associated with AR and it is role in initiating and maintaining AF. We will also discuss briefly the role of inflammation in AR and AF initiation and maintenance, as well as, the possible therapeutic interventions to prevent AR, and hence AF, based on the current understanding of the interaction between AF and AR.

摘要

心房颤动(AF)是临床实践中最常见的心律失常。AF的患病率随年龄急剧增加,80岁时高达9%的人会出现。在高危患者中,每年发生血栓栓塞性卒中的风险高达9%,且与死亡率增加两倍相关。尽管AF发生的病理生理机制一直是众多研究的重点,但仍仅部分被理解。传统理论聚焦于心房中存在多个折返环,这些折返环不同步,并以不同速度通过具有不同不应期的组织传导。最近,肺静脉开口处或肺静脉内肌袖中快速发放的心房活动被描述为潜在机制。AF是由各种起始触发因素与异常心房组织基质的发展之间的复杂相互作用导致的。AF的发展会导致心房发生结构和电变化,这一过程称为重塑。要有效地进行AF的外科手术或导管消融,深入了解可能的机制至关重要。一旦发生,AF会改变心房的电和结构特性,从而促进其维持和复发。在过去10至15年中,心房重塑(AR)在AF的发生和维持中的作用一直是许多动物和人体研究的主题。本综述将讨论AR的机制、与AR相关的结构、电生理和神经激素变化及其在启动和维持AF中的作用。我们还将简要讨论炎症在AR和AF启动及维持中的作用,以及基于目前对AF与AR相互作用的理解,预防AR进而预防AF的可能治疗干预措施。

相似文献

1
Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.
J Atr Fibrillation. 2009 Jun 1;2(1):125. doi: 10.4022/jafib.125. eCollection 2009 Jun-Jul.
2
Left Atrial Remodeling Mechanisms Associated with Atrial Fibrillation.
Cardiovasc Eng Technol. 2021 Jun;12(3):361-372. doi: 10.1007/s13239-021-00527-w. Epub 2021 Mar 1.
3
Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.
Circ Res. 2014 Apr 25;114(9):1483-99. doi: 10.1161/CIRCRESAHA.114.302226.
4
Pharmacological approaches in the treatment of atrial fibrillation.
Curr Med Chem. 2004 Jan;11(1):13-28. doi: 10.2174/0929867043456241.
6
Current concepts in the pathogenesis of atrial fibrillation.
Am Heart J. 2009 Feb;157(2):243-52. doi: 10.1016/j.ahj.2008.10.009. Epub 2008 Dec 24.
9
Electrophysiological properties of the fibrillating atrium: implications for therapy.
Clin Exp Pharmacol Physiol. 1998 May;25(5):293-302. doi: 10.1111/j.1440-1681.1998.tb02355.x.
10
Electrophysiological properties of the human atrium in atrial fibrillation.
Cardiovasc Res. 2002 May;54(2):302-14. doi: 10.1016/s0008-6363(02)00262-6.

引用本文的文献

1
The left atrium in heart failure with preserved ejection fraction: What we know and what we do not know.
Heart Rhythm O2. 2025 Apr 24;6(7):1028-1038. doi: 10.1016/j.hroo.2025.04.007. eCollection 2025 Jul.
3
Recent Advances in Understanding the Molecular Mechanisms of SGLT2 Inhibitors in Atrial Remodeling.
Curr Issues Mol Biol. 2024 Aug 31;46(9):9607-9623. doi: 10.3390/cimb46090571.
6
The application and mechanism of Chinese medicine in the upstream treatment of atrial fibrillation.
Front Cardiovasc Med. 2023 Aug 7;10:1229021. doi: 10.3389/fcvm.2023.1229021. eCollection 2023.
7
Rule-based definition of muscle bundles in patient-specific models of the left atrium.
Front Physiol. 2022 Oct 12;13:912947. doi: 10.3389/fphys.2022.912947. eCollection 2022.
8
miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium.
Int J Mol Sci. 2022 Jun 23;23(13):6962. doi: 10.3390/ijms23136962.
10
The Inverse Correlation Between the Duration of Lifetime Occupational Radiation Exposure and the Prevalence of Atrial Arrhythmia.
Front Cardiovasc Med. 2022 May 30;9:863939. doi: 10.3389/fcvm.2022.863939. eCollection 2022.

本文引用的文献

1
Atrial remodeling and atrial fibrillation: mechanisms and implications.
Circ Arrhythm Electrophysiol. 2008 Apr;1(1):62-73. doi: 10.1161/CIRCEP.107.754564.
3
Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
J Am Coll Cardiol. 2008 Feb 26;51(8):802-9. doi: 10.1016/j.jacc.2007.09.064.
5
Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):30-41. doi: 10.1038/ncpcardio1038.
6
Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure.
Am Heart J. 2007 Dec;154(6):1140-5. doi: 10.1016/j.ahj.2007.07.018. Epub 2007 Sep 14.
8
Management of atrial fibrillation in heart failure in the elderly.
Int J Cardiol. 2008 Apr 10;125(2):178-82. doi: 10.1016/j.ijcard.2007.10.008. Epub 2007 Oct 29.
9
Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.
J Am Coll Cardiol. 2007 Nov 20;50(21):2021-8. doi: 10.1016/j.jacc.2007.06.054. Epub 2007 Nov 5.
10
Statin use in chronic heart failure: waiting for the results of large prospective outcome trials.
Int J Cardiol. 2009 Feb 6;132(1):122-4; author reply 124-6. doi: 10.1016/j.ijcard.2007.06.122. Epub 2007 Sep 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验